Long non-coding RNA HOXD-AS1 in cancer

In conclusion, HOXD-AS1 may be considered as a promising diagnostic/prognostic biomarker or a novel therapeutic target for cancers.

https://www.sciencedirect.com/science/article/pii/S000989811830528X?dgcid=rss_sd...

Source: Clinica Chimica Acta - October 4, 2018 Category: Laboratory Medicine Source Type: research

More News: Bladder Cancer | Bone Cancers | Brain Tumor | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Glioma | Hepatocellular Carcinoma | Laboratory Medicine | Liver Cancer | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Osteosarcoma | Ovarian Cancer | Ovaries | Prostate Cancer | Skin Cancer